Siarez, Danilo, N/A. A.

HRN: 23-16-31  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2023
CEFTAZIDIME 1GM (VIAL)
10/17/2023
10/24/2023
IV
2g
Q8hr
Aspiration Pneumonia
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: